SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001607062-17-000122
Filing Date
2017-03-30
Accepted
2017-03-30 17:06:50
Documents
58
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A rgbp093115form10k.htm 10-K/A 1626942
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 9731
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 9872
4 EXHIBIT 32.1 ex32_1.htm EX-32.1 5918
5 EXHIBIT 32.2 ex32_2.htm EX-32.2 6096
  Complete submission text file 0001607062-17-000122.txt   4643128

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE rgbp-20150930.xml EX-101.INS 589485
7 XBRL SCHEMA FILE rgbp-20150930.xsd EX-101.SCH 43905
8 XBRL CALCULATION FILE rgbp-20150930_cal.xml EX-101.CAL 31565
9 XBRL DEFINITION FILE rgbp-20150930_def.xml EX-101.DEF 220732
10 XBRL LABEL FILE rgbp-20150930_lab.xml EX-101.LAB 204465
11 XBRL PRESENTATION FILE rgbp-20150930_pre.xml EX-101.PRE 249811
Mailing Address 4700 SPRING ST #304 LA MESA CA 91942
Business Address 4700 SPRING ST #304 LA MESA CA 91942 619-702-1404
Regen BioPharma Inc (Filer) CIK: 0001589150 (see all company filings)

IRS No.: 455192997 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-K/A | Act: 34 | File No.: 333-191725 | Film No.: 17726706
SIC: 2834 Pharmaceutical Preparations